C12N 2740/13021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2740/13021 (Viruses as such) appears on 13 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 16
- Assignees
- 20
- Inventors
- 39
- Latest grant
- 2 Sep 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 3 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 2 |
| 2021 | 0 | 0 |
| 2022 | 1 | 2 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 1 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells2 Sep 2025US 12,404,527 B2Selexs S.A.
- Strong insulator and uses thereof in gene delivery30 Apr 2024US 11,970,707 B2Children's Hospital Medical Center
- Recombinant vectors comprising 2A peptide22 Mar 2022US 11,279,949 B2Denovo Biopharma LLC
- Identification of a novel retrovirus in patients with benign prostatic hyperplasia18 Aug 2015US 9,107,892 B2University of Pittsburgh—Of the Commonwealth System of Higher Education
- Gammaretrovirus associated with cancer11 Sep 2012US 8,263,085 B2The Cleveland Clinic Foundation
- Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells13 Nov 2025US 2025/0346928 A1Selexis S.A.
- Methods and compositions for bat ipsc preparation and use19 Dec 2024US 2024/0417697 A1Icahn School of Medicine at Mount Sinai
- Characterization and inactivation of endogenous retroviruses in chinese hamster ovary cells24 Mar 2022US 2022/0090144 A1Selexis S.A.
- Recombinant vectors comprising genes for binding domains and secretable peptides6 Jan 2022US 2022/0002752 A1Denovo Biopharma LLC
- A strong insulator and uses thereof in gene delivery13 Aug 2020US 2020/0255860 A1Children's Hospital Medical Center
Most cited
By later US patents
- Stabilized retrovirus compositions15US 5,616,487 AAastrom Biosciences, Inc. · 1997
- Molecular sequences of swine retroviruses method of using6US 6,190,861 B1The General Hospital Corporation · 2001
- Molecular sequence of swine retrovirus2US 6,699,663 B1The General Hospital Corporation · 2004
- Encapsulated cells producing viral particles2US 6,776,985 B1Bavarian Nordic A/S · 2004
- Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens2US 6,800,469 B1NovImmune S.A. · 2004